120 related articles for article (PubMed ID: 7026270)
1. Semisynthesis and biological properties of the [B24-leucine]-, [B25-leucine[- and [B24-leucine, B25-leucine]-analogues of human insulin.
Inouye K; Watanabe K; Tochino Y; Kanaya T; Kobayashi M; Shigeta Y
Experientia; 1981; 37(8):811-3. PubMed ID: 7026270
[TBL] [Abstract][Full Text] [Related]
2. Semisynthesis and biological activity of porcine [LeuB24]insulin and [LeuB25]insulin.
Tager H; Thomas N; Assoian R; Rubenstein A; Saekow M; Olefsky J; Kaiser ET
Proc Natl Acad Sci U S A; 1980 Jun; 77(6):3181-5. PubMed ID: 6997872
[TBL] [Abstract][Full Text] [Related]
3. [LeuB24]insulin and [AlaB24]insulin: altered structures and cellular processing of B24-substituted insulin analogs.
Assoian RK; Thomas NE; Kaiser ET; Tager HS
Proc Natl Acad Sci U S A; 1982 Sep; 79(17):5147-51. PubMed ID: 6752939
[TBL] [Abstract][Full Text] [Related]
4. Insulin analogs with B24 or B25 phenylalanine replaced by biphenylalanine.
Du H; Shi J; Cui D; Zhang Y
Acta Biochim Biophys Sin (Shanghai); 2008 Feb; 40(2):133-9. PubMed ID: 18235975
[TBL] [Abstract][Full Text] [Related]
5. Semisynthetic insulin analogues modified in positions B24, B25 and B29.
Svoboda I; Brandenburg D; Barth T; Gattner HG; Jirácek J; Velek J; Bláha I; Ubik K; Kasicka V; Pospísek J
Biol Chem Hoppe Seyler; 1994 Jun; 375(6):373-8. PubMed ID: 7980868
[TBL] [Abstract][Full Text] [Related]
6. Structure-function relationships of shortened [LeuB25]insulins, semisynthetic analogues of a mutant human insulin.
Fischer WH; Saunders D; Brandenburg D; Diaconescu C; Wollmer A; Dodson G; De Meyts P; Zahn H
Biol Chem Hoppe Seyler; 1986 Sep; 367(9):999-1006. PubMed ID: 3539147
[TBL] [Abstract][Full Text] [Related]
7. Two mutant forms of human insulin. Structural consequences of the substitution of invariant B24- or B25-phenylalanine by leucine.
Wollmer A; Strassburger W; Glatter U; Dodson GG; McCall M; Gattner HG; Danho W; Brandenburg D; Rittel W
Hoppe Seylers Z Physiol Chem; 1981 Jun; 362(6):581-91. PubMed ID: 7024084
[TBL] [Abstract][Full Text] [Related]
8. Shortened insulin analogues: marked changes in biological activity resulting from replacement of TyrB26 and N-methylation of peptide bonds in the C-terminus of the B-chain.
Záková L; Barth T; Jirácek J; Barthová J; Zórad S
Biochemistry; 2004 Mar; 43(8):2323-31. PubMed ID: 14979729
[TBL] [Abstract][Full Text] [Related]
9. Structural determinants of ligand recognition by type I insulin-like growth factor receptors: use of semisynthetic insulin analog probes.
Cara JF; Nakagawa SH; Tager HS
Endocrinology; 1988 Jun; 122(6):2881-7. PubMed ID: 2967179
[TBL] [Abstract][Full Text] [Related]
10. Mutations at the dimer, hexamer, and receptor-binding surfaces of insulin independently affect insulin-insulin and insulin-receptor interactions.
Shoelson SE; Lu ZX; Parlautan L; Lynch CS; Weiss MA
Biochemistry; 1992 Feb; 31(6):1757-67. PubMed ID: 1737029
[TBL] [Abstract][Full Text] [Related]
11. Preparation and biological properties of [LeuB24, LeuB25]human insulin.
Jonczyk A; Keefer LM; Naithani VK; Gattner HG; De Meyts P; Zahn H
Hoppe Seylers Z Physiol Chem; 1981 May; 362(5):557-61. PubMed ID: 7019034
[No Abstract] [Full Text] [Related]
12. Shortened insulin with enhanced in vitro potency.
Casaretto M; Spoden M; Diaconescu C; Gattner HG; Zahn H; Brandenburg D; Wollmer A
Biol Chem Hoppe Seyler; 1987 Jun; 368(6):709-16. PubMed ID: 3304338
[TBL] [Abstract][Full Text] [Related]
13. Further studies on the three-step-increase in activity due to the aromatic amino acids B24-26 (-Phe-Phe-Tyr-).
Weitzel G; Bauer FU; Eisele K
Hoppe Seylers Z Physiol Chem; 1976 Feb; 357(2):187-200. PubMed ID: 1254246
[TBL] [Abstract][Full Text] [Related]
14. Negative and positive site-site interactions, and their modulation by pH, insulin analogs, and monoclonal antibodies, are preserved in the purified insulin receptor.
Wang CC; Goldfine ID; Fujita-Yamaguchi Y; Gattner HG; Brandenburg D; De Meyts P
Proc Natl Acad Sci U S A; 1988 Nov; 85(22):8400-4. PubMed ID: 3054887
[TBL] [Abstract][Full Text] [Related]
15. Immunoreactivity and biologic activity of semisynthetic [LeuB-30]-insulin: potential value in the treatment of insulin antibody-mediated insulin resistance.
Kobayashi M; Ohgaku S; Iwasaki M; Shigeta Y; Oka T; Morihara K
Diabetes; 1981 Jun; 30(6):519-23. PubMed ID: 7014315
[TBL] [Abstract][Full Text] [Related]
16. Decreased biologic activity and degradation of human [SerB24]-insulin, a second mutant insulin.
Haneda M; Kobayashi M; Maegawa H; Watanabe N; Takata Y; Ishibashi O; Shigeta Y; Inouye K
Diabetes; 1985 Jun; 34(6):568-73. PubMed ID: 3891469
[TBL] [Abstract][Full Text] [Related]
17. Relationship between negative cooperativity and insulin action.
Olefsky JM; Green A; Ciaraldi TP; Saekow M; Rubenstein AH; Tager HS
Biochemistry; 1981 Jul; 20(15):4488-92. PubMed ID: 7025901
[TBL] [Abstract][Full Text] [Related]
18. Impaired negative cooperativity of the semisynthetic analogues human [LeuB24]- and [LeuB25]-insulins.
Keefer LM; Piron MA; De Meyts P; Gattner HG; Diaconescu C; Saunders D; Brandenburg D
Biochem Biophys Res Commun; 1981 Jun; 100(3):1229-36. PubMed ID: 7023479
[No Abstract] [Full Text] [Related]
19. Mutational analysis of invariant valine B12 in insulin: implications for receptor binding.
Nakagawa SH; Tager HS; Steiner DF
Biochemistry; 2000 Dec; 39(51):15826-35. PubMed ID: 11123908
[TBL] [Abstract][Full Text] [Related]
20. Structural integrity of the B24 site in human insulin is important for hormone functionality.
Žáková L; Kletvíková E; Veverka V; Lepsík M; Watson CJ; Turkenburg JP; Jirácek J; Brzozowski AM
J Biol Chem; 2013 Apr; 288(15):10230-40. PubMed ID: 23447530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
